A chitosan thermogel for delivery of ropivacaine in regional musculoskeletal anesthesia

Biomaterials

Volumn 34, Issue 10, 2013, Pages 2539-2546

  Foley, Patricia L ^a   Ulery, Bret D ^b   Kan, Ho M ^b   Burks, Martin V ^c   Cui, Zhanwu ^b   Wu, Qian ^b   Nair, Lakshmi S ^b,d   Laurencin, Cato T ^b,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Anesthetics; Chitosan; Nanoparticles; Pain management; Thermogels

Indexed keywords

CLINICAL OUTCOME; DELIVERY SYSTEMS; DEXAMETHASONES; DRUG ACTION; DRUG DELIVERY SYSTEM; HALF LIVES; LOCAL ANESTHETICS; MICRO-PARTICLES; MOTOR FUNCTION; MUSCULOSKELETAL SURGERY; NEURAL BLOCKADE; OPTIMAL STRATEGIES; PAIN MANAGEMENT; ROPIVACAINE; SENSORY FUNCTIONS; THERMOGELS;

ANESTHETICS; DRUG DELIVERY; HEALTH; LIPOSOMES; MUSCULOSKELETAL SYSTEM; NANOPARTICLES; NEURAL NETWORKS; TISSUE;

CHITOSAN;

CHITOSAN; DEXAMETHASONE; NANOPARTICLE; ROPIVACAINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STRUCTURE; FEMALE; GEL; MOTOR PERFORMANCE; MUSCULOSKELETAL SYSTEM; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; RAT; REGIONAL ANESTHESIA; SCIATIC NERVE; SENSORY ANALYSIS;

AMIDES; ANESTHETICS, LOCAL; ANIMALS; CHITOSAN; DRUG DELIVERY SYSTEMS; FEMALE; MUSCULOSKELETAL PAIN; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84872676734     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.12.035     Document Type: Article

References (45)

1. Boezaart A.P., Davis G., Le-Wendling L. Recovery after orthopedic surgery: techniques to increase duration of pain control. Curr Opin Anaesthesiol 2012, 25:662-672.
2. Weldon C.B., Tsui J.H., Shankarappa S.A., Nguyen V.T., Ma M., Anderson D.G., et al. Electrospun drug-eluting sutures for local anesthesia. J Control Release 2012, 161:903-909.
3. Weston-Simons J.S., Pandit H., Haliker V., Dodd C.A., Popat M.T., Murray D.W. Intra-articular local anaesthetic on the day after surgery improves pain and patient satisfaction after unicompartmental knee replacement: a randomised controlled trial. Knee 2012, 19:352-355.
4. Curley J., Castillo J., Hotz J., Uezono M., Hernandez S., Lim J.O., et al. Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 1996, 84:1401-1410.
5. Epstein-Barash H., Shichor I., Kwon A.H., Hall S., Lawlor M.W., Langer R., et al. Prolonged duration local anesthesia with minimal toxicity. Proc Natl Acad Sci U S A 2009, 106:7125-7130.
6. Lee A.R., Yi H.-W., Chung I.S., Ko J.S., Ahn H.J., Gwak M.S., et al. Magnesium added to bupivacaine prolongs the duration of analgesia after interscalene nerve block. Can J Anaesth 2012, 59:21-27.
7. Fredrickson M.J., Abeysekera A., White R. Randomized study of the effect of local anesthetic volume and concentration on the duration of peripheral nerve blockade. Reg Anesth Pain Med 2012, 37:495-501.
8. Suzuki R., Arai Y.-C.P., Hamayasu K., Fujita K., Hara K., Yamaguchi T., et al. Complex of branched cyclodextrin and lidocaine prolonged the duration of peripheral nerve block. J Anesth 2009, 23:295-297.
9. Kiuchi M.G., Zapata-Sudo G., Trachez M.M., Ririe D., Sudo R.T. The influence of age on bupivacaine cardiotoxicity. Anesth Analg 2011, 112:574-580.
10. Hung C.-H., Liu K.-S., Shao D.-Z., Cheng K.-I., Chen Y.-C., Chen Y.-W. The systemic toxicity of equipotent proxymetacaine, oxybuprocaine, and bupivacaine during continuous intravenous infusion in rats. Anesth Analg 2010, 110:238-242.
11. Tsuchiya H., Ueno T., Mizogami M. Stereostructure-based differences in the interactions of cardiotoxic local anesthetics with cholesterol-containing biomimetic membranes. Bioorg Med Chem 2011, 19:3410-3415.
12. Takenami T., Wang G., Nara Y., Fukushima S., Yagishita S., Hiruma H., et al. Intrathecally administered ropivacaine is less neurotoxic than procaine, bupivacaine, and levobupivacaine in a rat spinal model. Can J Anaesth 2012, 59:456-465.
13. Klein S.M., Greengrass R.A., Steele S.M., D'Ercole F.J., Speer K.P., Gleason D.H., et al. A comparison of 0.5% bupivacaine, 0.5% ropivacaine, and 0.75% ropivacaine for interscalene brachial plexus block. Anesth Analg 1998, 87:1316-1319.
14. Nava-Ocampo A.A., Bello-Ramirez A.M. Lipophilicity affects the pharmacokinetics and toxicity of local anaesthetic agents administered by caudal block. Clin Exp Pharmacol Physiol 2004, 31:116-118.
15. Ratajczak-Enselme M., Estebe J.-P., Rose F.-X., Wodey E., Malinovsky J.-M., Chevanne F., et al. Effect of epinephrine on epidural, intrathecal, and plasma pharmacokinetics of ropivacaine and bupivacaine in sheep. Br J Anaesth 2007, 99:881-890.
16. Winkler T., Suda A.J., Dumitrescu R.V., Pinggera O., Weber G., Loho G., et al. Interscalene versus subacromial continuous infusion of ropivacaine after arthroscopic acromioplasty: a randomized controlled trial. J Shoulder Elbow Surg 2009, 18:566-572.
17. Dragoo J.L., Brian H.J., Kim H.J., Phan H.D., Golish S.R. The in vitro chondrotoxicity of single-dose local anesthetics. Am J Sports Med 2012, 40:794-799.
18. Chen Y.-W., Wang J.-J., Liu T.-Y., Chen Y.-C., Hung C.-H. Systemic dextromethorphan and dextrorphan are less toxic in rats than bupivacaine at equianesthetic doses. Can J Anaesth 2011, 58:55-61.
19. Cheung H.M.C., Lee S.M., MacLeod B.A., Ries C.R., Schwarz S.K.W. A comparison of the systemic toxicity of lidocaine versus its quaternary derivative QX-314 in mice. Can J Anaesth 2011, 58:443-450.
20. Colombo G., Langer R., Kohane D.S. Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve. J Biomed Mater Res A 2004, 68A:651-659.
21. Grillo R., de Melo N.F., de Araujo D.R., de Paula E., Rosa A.H., Fraceto L.F. Polymeric alginate nanoparticles containing the local anesthetic bupivacaine. J Drug Target 2010, 18:688-699.
22. Kloxin A.M., Tibbitt M.W., Anseth K.S. Synthesis of photodegradable hydrogels as dynamically tunable cell culture platforms. Nat Protoc 2010, 5:1867-1887.
23. Phadke A., Zhang C., Arman B., Hsu C.-C., Mashelkar R.A., Lele A.K., et al. Rapid self-healing hydrogels. Proc Natl Acad Sci U S A 2012, 109:4383-4388.
24. Kim I.L., Mauck R.L., Burdick J.A. Hydrogel design for cartilage tissue engineering: a case study with hyaluronic acid. Biomaterials 2011, 32:8771-8782.
25. Hale B.W., Goodrich L.R., Frisbie D.D., McIlwraith C.W., Kisiday J.D. Effect of scaffold dilution on migration of mesenchymal stem cells from fibrin hydrogels. Am J Vet Res 2012, 73:313-318.
26. Chenite A., Chaput C., Wang D., Combes C., Buschmann M.D., Hoemann C.D., et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 2000, 21:2155-2161.
27. Ruel-Gariepy E., Leclair G., Hildgen P., Gupta A., Leroux J.C. Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J Control Release 2002, 82:373-383.
28. McLaughlin S.W., Cui Z., Starnes T., Laurencin C.T., Kan H.-M., Wu Q., et al. Injectable thermogelling chitosan for the local delivery of bone morphogenetic protein. J Mater Sci Mater Med 2012, 23:2141-2149.
29. Nair L.S., Starnes T., Ko J.-W.K., Laurencin C.T. Development of injectable thermogelling chitosan-inorganic phosphate solutions for biomedical applications. Biomacromolecules 2007, 8:3779-3785.
30. Wu Z.M., Zhang X.G., Zheng C., Li C.X., Zhang S.M., Dong R.N., et al. Disulfide-crosslinked chitosan hydrogel for cell viability and controlled protein release. Eur J Pharm Sci 2009, 37:198-206.
31. Moura M.J., Faneca H., Lima M.P., Gil M.H., Figueiredo M.M. In situ forming chitosan hydrogels prepared via ionic/covalent co-cross-linking. Biomacromolecules 2011, 12:3275-3284.
32. Lee K.C., Wilder R.T., Smith R.L., Berde C.B. Thermal hyperalgesia accelerates and MK-801 prevents the development of tachyphylaxis to rat sciatic nerve blockade. Anesthesiology 1994, 81:1284-1293.
33. Naropin (ropivacaine HCl) injection drug approval package 2nd November 2000, United States Food and Drug Administration.
34. Piper S.L., Kim H.T. Comparison of ropivacaine and bupivacaine toxicity in human articular chondrocytes. J Bone Joint Surg Am 2008, 90:986-991.
35. Piper S.L., Kramer J.D., Kim H.T., Feeley B.T. Effects of local anesthetics on articular cartilage. Am J Sports Med 2011, 39:2245-2253.
36. Butterworth J.F., Strichartz G.R. Molecular mechanisms of local anesthesia: a review. Anesthesiology 1990, 72:711-734.
37. Cousins M.J., Bridenbaugh P.O. Neural blockade in clinical anesthesia and management of pain 2008, Lippincott-Raven Publishers, Philadelphia, PA. 3rd ed.
38. Thomas J.M., Schug S.A. Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions. Clin Pharm 1999, 36:67-83.
39. Bigeleisen P.E., Wempe M. Identification of the precipitate in alkinized solutions of mepivacaine and bupivacaine at 37 degrees C. J Clin Pharm Ther 2001, 26:171-173.
40. Milner Q.J., Guard B.C., Allen J.G. Alkalinatization of amide local anaesthetics by addition of 1% sodium bicarbonate solution. Eur J Anaesthesiol 2000, 17:38-42.
41. Lai F., Sinico C., Ennas G., Marongiu F., Marongiu G., Fadda A.M. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. Int J Pharm 2009, 373:124-132.
42. Armstead A.L., Li B. Nanomedicine as an emerging approach against intracellular pathogens. Int J Nanomed 2011, 6:3281-3293.
43. Lim S.M., Song D.K., Oh S.H., Lee-Yoon D.S., Bae E.H., Lee J.H. In vitro and in vivo degradation behavior of acetylated chitosan porous beads. J Biomater Sci Polym Ed 2008, 19:453-466.
44. Ito T., Fraser I.P., Yeo Y., Highley C.B., Bellas E., Kohane D.S. Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. Biomaterials 2007, 28:1778-1786.
45. Mercanzini A., Reddy S.T., Velluto D., Colin P., Maillard A., Bensadoun J.C., et al. Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses. J Control Release 2010, 145:196-202.